Form 4 for BCPC BALCHEM CORP
Accepted 2024-02-12 00:00:00 ET · period of report 2024-02-08 · accession 0001140361-24-007148 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-12 | 2024-02-08 | BCPC | Boned Frederic | SVP, GM, Human Nutri, Health | A - Grant | $0.00 | +1,380 | 5,322 | +35% | $0 |
| D | 2024-02-12 | 2024-02-08 | BCPC | Boned Frederic | SVP, GM, Human Nutri, Health | A - Grant | $0.00 | +4,500 | 4,500 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-08 | A | A | 1,380 | $0.00 | 5,322 | D | — | — | (F1) Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. (F2) Includes acquisition of shares under the Balchem Corporation 401(k) plan. |
| 2 | Derivative | Stock Option | 2024-02-08 | A | A | 4,500 | $0.00 | 4,500 | D | $143.43 · — to 2034-02-08 | 4,500 Common Stock | (F3) Options vest 20% Year 1; 40% Year 2: and 40% Year 3. |